Ledger.Open graph →
SEC Form D · filed February 12, 2015

Vasculox, Inc

Offering
$2.8M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAINT LOUIS, MO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Robert W. Karr · SAINT LOUIS, MOExec · DirectorJohn W. Mckearn · SAINT LOUIS, MODirectorPamela W. Manning · SAINT LOUIS, MOExecCharles Bolten · SAINT LOUIS, MODirectorWilliam Frazier · SAINT LOUIS, MODirectorDan Broderick · SAINT LOUIS, MODirectorDaniel S. Lovell · Dallas, TXExecBill L. Maley · WILMINGTON, DEExec · DirectorTimothy C. Nichols · Dallas, TXDirectorKalthleen L. Beckmann · SAINT LOUIS, MOExecCharles Bolten · St. Louis, MODirectorBobby W. Sandage, Jr · SAINT LOUIS, MODirectorDavid J. Makula · CHICAGO, ILExec · DirectorPhilip Dickie · Grand Cayman, Cayman IslandsExecKeith Johnson · Menlo Park, CADirectorKalthleen L. Beckmann · SAINT LOUIS, MOExecCharles Bolten · Saint Louis, MODirectorBobby W. Sandage, Jr · SAINT LOUIS, MODirectorWilliam Frazier · SAINT LOUIS, MODirectorDan Broderick · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗